High-intensity Focused Ultrasound Treatment in Moderate Glaucoma Patients: Results of a 2-Year Prospective Clinical Trial

Ultrasound Cyclo Plasty (UCP) treatment using high-intensity focused ultrasound (HIFU) is an effective and safe therapy to reduce intraocular pressure (IOP) in moderate glaucoma patients as was measured during a 2-year follow-up period. The purpose of this study was to evaluate the long-term safety...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of glaucoma Jg. 29; H. 7; S. 556
Hauptverfasser: Leshno, Ari, Rubinstein, Yair, Singer, Reut, Sher, Ifat, Rotenstreich, Ygal, Melamed, Shlomo, Skaat, Alon
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States 01.07.2020
Schlagworte:
Aged
Aged, 80 and over
Ciliary Body - surgery
Female
Follow-Up Studies
Glaucoma, Open-Angle - physiopathology
Glaucoma, Open-Angle - surgery
High-Intensity Focused Ultrasound Ablation - methods
Humans
Intraocular Pressure - physiology
Male
Middle Aged
Postoperative Complications - surgery
Prospective Studies
Slit Lamp Microscopy
Tonometry, Ocular
Treatment Outcome
ISSN:1536-481X, 1536-481X
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Ultrasound Cyclo Plasty (UCP) treatment using high-intensity focused ultrasound (HIFU) is an effective and safe therapy to reduce intraocular pressure (IOP) in moderate glaucoma patients as was measured during a 2-year follow-up period. The purpose of this study was to evaluate the long-term safety and efficacy of the UCP procedure using HIFU in moderate glaucoma patients. A prospective interventional noncomparative study was carried out. Fifteen patients (15 eyes) with moderate open-angle glaucoma were enrolled. All eyes were treated with UCP-HIFU. A thorough ophthalmic examination and IOP measurements were performed before the UCP-HIFU procedure and at 1 day, 1 week, 4 weeks, 3 months, 6 months, 1 year, and 2 years after the procedure. The primary outcome was defined as a surgical success (IOP reduction of 20% or ≥5 mm Hg) at the last follow-up visit. The secondary outcomes were the mean IOP at each follow-up visit, number of medications used, complications profile, and reinterventions. The mean preoperative IOP at baseline was 26.8±5.0 mm Hg. All patients had a positive response and a lower IOP after treatment, with a relatively stable 31% reduction in IOP during the follow-up period. A significant reduction in IOP was observed at all postprocedure examination points (P<0.01), with a mean 17.6±4.4 mm Hg at 2 years after the procedure (P=0.005). Surgical success was achieved in 87% of the patients at their last follow-up visit. There was a nonsignificant decrease in the mean number of glaucoma medications from 2.5±0.8 to 2.0±1.0 at 2 years (P=0.48). No major intraoperative or postoperative complications were noted. UCP-HIFU treatment is an effective, safe, and well-tolerated method to reduce IOP in patients with moderate glaucoma.
AbstractList Ultrasound Cyclo Plasty (UCP) treatment using high-intensity focused ultrasound (HIFU) is an effective and safe therapy to reduce intraocular pressure (IOP) in moderate glaucoma patients as was measured during a 2-year follow-up period. The purpose of this study was to evaluate the long-term safety and efficacy of the UCP procedure using HIFU in moderate glaucoma patients. A prospective interventional noncomparative study was carried out. Fifteen patients (15 eyes) with moderate open-angle glaucoma were enrolled. All eyes were treated with UCP-HIFU. A thorough ophthalmic examination and IOP measurements were performed before the UCP-HIFU procedure and at 1 day, 1 week, 4 weeks, 3 months, 6 months, 1 year, and 2 years after the procedure. The primary outcome was defined as a surgical success (IOP reduction of 20% or ≥5 mm Hg) at the last follow-up visit. The secondary outcomes were the mean IOP at each follow-up visit, number of medications used, complications profile, and reinterventions. The mean preoperative IOP at baseline was 26.8±5.0 mm Hg. All patients had a positive response and a lower IOP after treatment, with a relatively stable 31% reduction in IOP during the follow-up period. A significant reduction in IOP was observed at all postprocedure examination points (P<0.01), with a mean 17.6±4.4 mm Hg at 2 years after the procedure (P=0.005). Surgical success was achieved in 87% of the patients at their last follow-up visit. There was a nonsignificant decrease in the mean number of glaucoma medications from 2.5±0.8 to 2.0±1.0 at 2 years (P=0.48). No major intraoperative or postoperative complications were noted. UCP-HIFU treatment is an effective, safe, and well-tolerated method to reduce IOP in patients with moderate glaucoma.
Ultrasound Cyclo Plasty (UCP) treatment using high-intensity focused ultrasound (HIFU) is an effective and safe therapy to reduce intraocular pressure (IOP) in moderate glaucoma patients as was measured during a 2-year follow-up period.PRECISUltrasound Cyclo Plasty (UCP) treatment using high-intensity focused ultrasound (HIFU) is an effective and safe therapy to reduce intraocular pressure (IOP) in moderate glaucoma patients as was measured during a 2-year follow-up period.The purpose of this study was to evaluate the long-term safety and efficacy of the UCP procedure using HIFU in moderate glaucoma patients.PURPOSEThe purpose of this study was to evaluate the long-term safety and efficacy of the UCP procedure using HIFU in moderate glaucoma patients.A prospective interventional noncomparative study was carried out. Fifteen patients (15 eyes) with moderate open-angle glaucoma were enrolled. All eyes were treated with UCP-HIFU. A thorough ophthalmic examination and IOP measurements were performed before the UCP-HIFU procedure and at 1 day, 1 week, 4 weeks, 3 months, 6 months, 1 year, and 2 years after the procedure. The primary outcome was defined as a surgical success (IOP reduction of 20% or ≥5 mm Hg) at the last follow-up visit. The secondary outcomes were the mean IOP at each follow-up visit, number of medications used, complications profile, and reinterventions.PATIENTS AND METHODSA prospective interventional noncomparative study was carried out. Fifteen patients (15 eyes) with moderate open-angle glaucoma were enrolled. All eyes were treated with UCP-HIFU. A thorough ophthalmic examination and IOP measurements were performed before the UCP-HIFU procedure and at 1 day, 1 week, 4 weeks, 3 months, 6 months, 1 year, and 2 years after the procedure. The primary outcome was defined as a surgical success (IOP reduction of 20% or ≥5 mm Hg) at the last follow-up visit. The secondary outcomes were the mean IOP at each follow-up visit, number of medications used, complications profile, and reinterventions.The mean preoperative IOP at baseline was 26.8±5.0 mm Hg. All patients had a positive response and a lower IOP after treatment, with a relatively stable 31% reduction in IOP during the follow-up period. A significant reduction in IOP was observed at all postprocedure examination points (P<0.01), with a mean 17.6±4.4 mm Hg at 2 years after the procedure (P=0.005). Surgical success was achieved in 87% of the patients at their last follow-up visit. There was a nonsignificant decrease in the mean number of glaucoma medications from 2.5±0.8 to 2.0±1.0 at 2 years (P=0.48). No major intraoperative or postoperative complications were noted.RESULTSThe mean preoperative IOP at baseline was 26.8±5.0 mm Hg. All patients had a positive response and a lower IOP after treatment, with a relatively stable 31% reduction in IOP during the follow-up period. A significant reduction in IOP was observed at all postprocedure examination points (P<0.01), with a mean 17.6±4.4 mm Hg at 2 years after the procedure (P=0.005). Surgical success was achieved in 87% of the patients at their last follow-up visit. There was a nonsignificant decrease in the mean number of glaucoma medications from 2.5±0.8 to 2.0±1.0 at 2 years (P=0.48). No major intraoperative or postoperative complications were noted.UCP-HIFU treatment is an effective, safe, and well-tolerated method to reduce IOP in patients with moderate glaucoma.CONCLUSIONUCP-HIFU treatment is an effective, safe, and well-tolerated method to reduce IOP in patients with moderate glaucoma.
Author Rubinstein, Yair
Sher, Ifat
Rotenstreich, Ygal
Skaat, Alon
Melamed, Shlomo
Singer, Reut
Leshno, Ari
Author_xml – sequence: 1
  givenname: Ari
  surname: Leshno
  fullname: Leshno, Ari
  organization: Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
– sequence: 2
  givenname: Yair
  surname: Rubinstein
  fullname: Rubinstein, Yair
  organization: Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
– sequence: 3
  givenname: Reut
  surname: Singer
  fullname: Singer, Reut
  organization: Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
– sequence: 4
  givenname: Ifat
  surname: Sher
  fullname: Sher, Ifat
  organization: Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
– sequence: 5
  givenname: Ygal
  surname: Rotenstreich
  fullname: Rotenstreich, Ygal
  organization: Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
– sequence: 6
  givenname: Shlomo
  surname: Melamed
  fullname: Melamed, Shlomo
  organization: Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
– sequence: 7
  givenname: Alon
  surname: Skaat
  fullname: Skaat, Alon
  organization: Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32217996$$D View this record in MEDLINE/PubMed
BookMark eNpNUEtLAzEYDFKxtvoPRHL0sjXJPpJ4k2IfUrFIBT2VbPZbjWSTuskK_fcuWKFzmYEZhmFGaOC8A4SuKJlQIvnt8nE-IUegmeQn6JzmaZFkgr4NjvQQjUL4IoQRxugZGqY9cSmLc7RfmI_PxLgILpi4xzOvuwAVfrWxVcF3rsKbFlRswEVsHH7yFbQqAp5b1WnfKLxW0fRmuMMvEDobA_Y1Vpgl76BavG592IGO5gfw1BpntLJ9o1H2Ap3Wyga4PPAYbWYPm-kiWT3Pl9P7VaLTnMmkLsosl6KsdaU15ypVBeuXp6IoeV6LkkGV1gWtQVcZV1lOhcwJ5USXQkoi2Bjd_NXuWv_dQYjbxgQN1ioHvgtbloqMkZQWWR-9PkS7soFqu2tNo9r99v8t9gs3i2-r
CitedBy_id crossref_primary_10_1186_s12886_022_02622_5
crossref_primary_10_1177_11206721241235430
crossref_primary_10_3390_mi15060786
crossref_primary_10_1038_s41598_021_92233_9
crossref_primary_10_1159_000515013
crossref_primary_10_1080_17469899_2021_1902309
crossref_primary_10_3389_fmed_2022_1009273
crossref_primary_10_1111_aos_15290
crossref_primary_10_3390_jcm10214982
crossref_primary_10_1097_IJG_0000000000002185
crossref_primary_10_1097_IJG_0000000000001796
crossref_primary_10_1007_s10792_023_02818_8
crossref_primary_10_1002_jcu_23214
crossref_primary_10_3390_mi13081362
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1097/IJG.0000000000001497
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1536-481X
ExternalDocumentID 32217996
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.-D
.Z2
0R~
2V-
53G
5GY
5VS
8L-
AAAAV
AAHPQ
AAIQE
AARTV
AASCR
AAYEP
ABASU
ABBUW
ABDIG
ABJNI
ABOCM
ABVCZ
ABXRP
ABXVJ
ABZAD
ABZZY
ACCJW
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACWDW
ACWRI
ACXJB
ACXNZ
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AE6
AEETU
AENEX
AFBFQ
AFDTB
AFUWQ
AGINI
AHQNM
AHRYX
AHVBC
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BQLVK
BS7
C45
CGR
CS3
CUY
CVF
DIWNM
DU5
DUNZO
E.X
EBS
ECM
EEVPB
EIF
EJD
EX3
F2K
F2L
F5P
FCALG
FL-
GNXGY
GQDEL
H0~
HLJTE
HZ~
IKREB
IN~
IPNFZ
JK3
JK8
K8S
KD2
KMI
L-C
N9A
NPM
N~M
O9-
OCUKA
ODA
OL1
OLG
OLV
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OXXIT
P-K
P2P
R58
RIG
RLZ
S4R
S4S
TEORI
TSPGW
V2I
W3M
WOQ
WOW
X3V
X3W
YFH
ZB8
ZFV
ZZMQN
7X8
ABPXF
ADKSD
ID FETCH-LOGICAL-c3529-f6b4598bfcdcc77a3a62996386b75f8b2ed3f61fecd47a4518950170cb899082
IEDL.DBID 7X8
ISICitedReferencesCount 15
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000559090500017&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1536-481X
IngestDate Thu Oct 02 10:04:20 EDT 2025
Thu Apr 03 07:03:32 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 7
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3529-f6b4598bfcdcc77a3a62996386b75f8b2ed3f61fecd47a4518950170cb899082
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 32217996
PQID 2384203164
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2384203164
pubmed_primary_32217996
PublicationCentury 2000
PublicationDate 2020-07-00
20200701
PublicationDateYYYYMMDD 2020-07-01
PublicationDate_xml – month: 07
  year: 2020
  text: 2020-07-00
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of glaucoma
PublicationTitleAlternate J Glaucoma
PublicationYear 2020
SSID ssj0020221
Score 2.35325
Snippet Ultrasound Cyclo Plasty (UCP) treatment using high-intensity focused ultrasound (HIFU) is an effective and safe therapy to reduce intraocular pressure (IOP) in...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 556
SubjectTerms Aged
Aged, 80 and over
Ciliary Body - surgery
Female
Follow-Up Studies
Glaucoma, Open-Angle - physiopathology
Glaucoma, Open-Angle - surgery
High-Intensity Focused Ultrasound Ablation - methods
Humans
Intraocular Pressure - physiology
Male
Middle Aged
Postoperative Complications - surgery
Prospective Studies
Slit Lamp Microscopy
Tonometry, Ocular
Treatment Outcome
Title High-intensity Focused Ultrasound Treatment in Moderate Glaucoma Patients: Results of a 2-Year Prospective Clinical Trial
URI https://www.ncbi.nlm.nih.gov/pubmed/32217996
https://www.proquest.com/docview/2384203164
Volume 29
WOSCitedRecordID wos000559090500017&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFA7qRHzxfpk3IvgaZts0aX0RETcVN4ZMmE8jTU9gMNq5bsL-vSdtqk-CYB76lhKSc_lOzsl3CLmKNJeBTiSTCYSMY_DFFISKiTQWEqRMjS7Z9V9krxcNh3HfXbgVrqyytomloU5zbe_IW-hauI8SKPjt9IPZrlE2u-paaKySRoBQxiqmHH5nETCu9x1fqmA88ob107lYtp6eOxV1oRsYKMjfQWbpbNrb_13mDtlyMJPeVXKxS1Yg2yMbXZdI3ydLW9_BxlX9-nxJ27leFJDSt8l8pgrbaokO6hJ0Os5o2TINYSntTNQCV6JovyJkLW7oKxSLybyguaGK-uwddYf2Z3n9hpM66tEJ_hGF_YAM2g-D-0fmujAwjeAsZkYkPIyjxOhUaylVoAS6MFRbkcjQRIkPaWCEZ0CnXCoeelEcWlIenWAohwDjkKxleQbHhCI0DsALILnmwI3QEQ9wfqwMoBkAD5rkst7TEQq5zVyoDPJFMfrZ1SY5qg5mNK3YOEZokSyrnTj5w-xTsunbeLkstz0jDYMqDudkXX_Ox8XsopQe_Pb63S85Uc8t
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High-intensity+Focused+Ultrasound+Treatment+in+Moderate+Glaucoma+Patients%3A+Results+of+a+2-Year+Prospective+Clinical+Trial&rft.jtitle=Journal+of+glaucoma&rft.au=Leshno%2C+Ari&rft.au=Rubinstein%2C+Yair&rft.au=Singer%2C+Reut&rft.au=Sher%2C+Ifat&rft.date=2020-07-01&rft.issn=1536-481X&rft.eissn=1536-481X&rft.volume=29&rft.issue=7&rft.spage=556&rft_id=info:doi/10.1097%2FIJG.0000000000001497&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1536-481X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1536-481X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1536-481X&client=summon